Myeloproliforative Disorder
Randomized, open-label, multicenter phase 3 study to assess the efficacy and safety of GIVinostat versus hydroxyurea IN JAK2V617F-positive high-risk Polycythemia Vera patients: the GIV-IN PV TRIAL (DSC/08/2357/32)
- Details
ClinicalTrials.gov ID:
NCT06093672
Diagnosis Type:
NA
USOR Number:
- Address
,
P: